Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

0.49 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Revenue 002.8460000000000000000
Cost of Revenue 0.1350.1370.1350.4550.4910.4770.4690.4510.440.4480.3290.1360.1220.09800000
Gross Profit -0.135-0.1372.711-0.455-0.491-0.477-0.469-0.451-0.44-0.448-0.329-0.136-0.122-0.09800000
Gross Profit Ratio 000.9530000000000000000
Reseach & Development Expenses 4.5844.9174.4933.8184.7845.2047.3459.196.3937.4555.9566.4435.8983.3652.5563.5762.8582.1952.425
General & Administrative Expenses 3.2033.8133.6493.9195.3935.8045.7034.7514.3195.0323.4573.8733.8864.6042.5211.7881.3111.9080.982
Selling & Marketing Expenses -0.135-0.137-0.1350000000000000000
SG&A 3.0683.6763.5143.9195.3935.8045.7034.7514.3195.0323.4573.8733.8864.6042.5211.7881.3111.9080.982
Other Expenses 0-0.002-0.0670.6130.0680.8311.5650.020000.631-0.028-0.0030.7380000
Operating Expenses 7.6528.5938.0077.73710.17711.00813.04813.94110.71212.4879.41310.3169.7847.9695.0775.3644.1694.1033.407
Operating Income -7.787-8.73-8.142-7.737-10.177-11.008-13.048-13.941-10.712-12.487-9.413-10.316-9.784-7.969-5.077-5.364-4.907-4.103-3.407
Operating Income Ratio 00-2.8610000000000000000
Total Other Income Expenses Net 0.6450.7380.7280.613-0.1230.8310.8160.5250.1770.0820.0190.631-0.028-0.003-1.689-0.003-0.7381.04-1.902
Income Before Tax -7.142-7.992-7.414-7.124-9.386-10.177-12.232-13.416-10.535-12.405-9.366-9.685-9.771-7.972-5.131-5.367-4.91-4.692-6.705
Income Before Tax Ratio 00-2.6050000000000000000
Income Tax Expense 00.0941.457-0.3320.106-1.2310.209-0.525-0.177-0.082-0.047-0.631-0.0130.0030.0540.0030.0030.5893.298
Net Income -7.142-7.992-7.414-7.124-9.386-8.946-12.441-12.891-10.358-12.323-9.366-9.685-9.771-7.972-5.131-5.367-4.91-4.692-6.705
Net Income Ratio 00-2.6050000000000000000
EPS -0.28-0.32-0.3-0.28-0.31-0.29-0.4-0.42-0.34-0.4-0.31-0.32-0.32-0.42-0.27-0.44-0.4-0.38-0.54
EPS Diluted -0.28-0.32-0.3-0.28-0.31-0.29-0.4-0.42-0.34-0.4-0.31-0.32-0.32-0.42-0.27-0.44-0.4-0.38-0.54
EBITDA -7.652-8.593-8.007-7.737-8.825-11.008-14.257-13.064-10.043-11.843-8.75-10.316-9.624-7.969-5.334-5.3-4.117-4.08-3.384
EBITDA Ratio 00-2.8130000000000000000